Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients

Despite major therapeutic advancements, multiple myeloma (MM) is still incurable and relapsed/refractory multiple myeloma (RRMM) remains a challenge; the rational choice of the most appropriate regimen in this setting is currently undefined. We performed a systematic review and 2 standard pairwise m...

Full description

Saved in:
Bibliographic Details
Published in:Blood Adv
Main Authors: Botta, Cirino, Ciliberto, Domenico, Rossi, Marco, Staropoli, Nicoletta, Cucè, Maria, Galeano, Teresa, Tagliaferri, Pierosandro, Tassone, Pierfrancesco
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2017
Subjects:
Lymphoid Neoplasia
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738982/
https://ncbi.nlm.nih.gov/pubmed/29296961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016003905
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items